
Number of publications published per year by Minguez, Beatriz. (Source : PubMed)

Distribution of publications types for Minguez, Beatriz. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
J. Hepatol.
2010;52;4
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.
Semin. Liver Dis.
2010;30;1

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
Annu. Rev. Med.
2010;61

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
J. Hepatol.
2009;51;4

Pathogenesis of hepatocellular carcinoma and molecular therapies.
Curr. Opin. Gastroenterol.
2009;25;3



Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology
2008;135;6

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Res.
2008;68;16

Hepatic encephalopathy.
Semin. Liver Dis.
2008;28;1
Decreased white matter lesion volume and improved cognitive function after liver transplantation.
Hepatology
2007;46;5
Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
Hepatology
2006;43;4
[ See timeline ] [ See all publications ]
means that Minguez, Beatriz has 9 papers cited a least 9 times - methodology
Mount Sinai Liver Cancer Program, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, NY 10029, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.